Show
Sort by
-
What can platinum offer yet in the treatment of PS2 NSCLC patients?: a systematic review and meta-analysis
-
- Journal Article
- A1
- open access
Rehabilitation in patients with radically treated respiratory cancer : a randomised controlled trial comparing two training modalities
-
Use of the lung cancer-specific quality of life questionnaire EORTC QLQ-LC13 in clinical trials: a systematic review of the literature 20 years after its development
-
- Journal Article
- A1
- open access
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
-
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma: a hypothesis
-
A rare cause of haemoptysis
-
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
-
The effect of radical treatment and rehabilitation on muscle mass and strength: a randomized trial in stages I-III lung cancer patients
-
Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study)
-
A breath test for diagnosing malignant pleural mesothelioma
-
Functional respiratory imaging to predict post-operative FEV1 after lobectomy/pneumonectomy
-
Functional respiratory imaging to predict post-operative forced expiratory
-
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation
-
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment?: biological, pharmacological and clinical aspects
-
- Journal Article
- A1
- open access
Supplementary prognostic variables for pleural mesothelioma : a report from the IASLC Staging Committee